UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 90 filers reported holding UROGEN PHARMA LTD in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $622,000 | +229.1% | 71,392 | +258.5% | 0.00% | – |
| Q4 2021 | $189,000 | -84.2% | 19,912 | -72.0% | 0.00% | -100.0% |
| Q3 2021 | $1,195,000 | +20.1% | 71,045 | +9.0% | 0.00% | 0.0% |
| Q2 2021 | $995,000 | +247.9% | 65,179 | +343.7% | 0.00% | – |
| Q1 2021 | $286,000 | -44.9% | 14,690 | -49.0% | 0.00% | – |
| Q4 2020 | $519,000 | -5.3% | 28,819 | +1.4% | 0.00% | – |
| Q3 2020 | $548,000 | -17.2% | 28,423 | +12.2% | 0.00% | -100.0% |
| Q2 2020 | $662,000 | +49.8% | 25,328 | +2.3% | 0.00% | – |
| Q1 2020 | $442,000 | -36.8% | 24,749 | +18.1% | 0.00% | -100.0% |
| Q4 2019 | $699,000 | +48.7% | 20,957 | +6.3% | 0.00% | – |
| Q3 2019 | $470,000 | +114.6% | 19,720 | +223.7% | 0.00% | – |
| Q2 2019 | $219,000 | – | 6,093 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 789,297 | $39,275,000 | 60.44% |
| Wildcat Capital Management, LLC | 251,459 | $12,513,000 | 9.57% |
| Consonance Capital Management LP | 1,487,491 | $74,018,000 | 4.77% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,499,870 | $124,394,000 | 3.53% |
| MEITAV INVESTMENT HOUSE LTD | 509,355 | $29,967,000 | 1.34% |
| DSAM Partners (London) Ltd | 127,588 | $6,349,000 | 1.28% |
| SHIKIAR ASSET MANAGEMENT INC | 48,125 | $2,395,000 | 1.00% |
| BANK HAPOALIM BM | 67,125 | $3,340,000 | 0.91% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 331,900 | $16,515,000 | 0.55% |
| Clal Insurance Enterprises Holdings Ltd | 310,000 | $15,426,000 | 0.40% |